UNITAID is an international drug-purchasing facility, supporting projects which use UNITAID’s long-term sustainable funding to positively impact the market for medicines and other health products for HIV/AIDS, TB and Malaria. The Civil Society delegations to UNITAID Board (representing NGOs and Communities affected by HIV/AIDS, TB and Malaria at Board level) recently attended the UNITAID Executive Board Retreat, from 29th-31st March 2011. This meeting posed two main questions for discussion between UNITAID Board members and UNITAID implementing partners:
- Is UNITAID doing the right things?
Is UNITAID doing things right?
Discussions encompassed a broad range of topics grouped under these questions, including:
The global health landscape and future needs in HIV/AIDS, TB and malaria
- UNITAID’s prioritisation of areas within the 3 diseases to fund, and proposal process
- Principles underlying UNITAID’s portfolio of projects
- UNITAID’s strategy for transitioning projects to alternative funders (where the market impact for a particular commodity has been maximised)
- Resource mobilisation